Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2022; 19(9):1430-1441. doi:10.7150/ijms.60335 This issue Cite

Research Paper

FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells

Zi-Meng Zheng1,2, Ying-Ying Wang3, Min Chen1,2, Hui-Li Yang1,2, Zhen-Zhen Lai1,2, Ming-Qing Li1,2,4, Jun Shao1✉

1. Insitute of Obstetrics and Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200082, People's Republic of China.
2. NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200082, People's Republic of China.
3. Department of Obstetrics and Gynecology, Yidu Central Hospital of Weifang, Weifang 262500, People's Republic of China.
4. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai 200011, People's Republic of China.

✉ Corresponding author: Jun Shao, E-mail: junshaoedu.cn; NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Hospital of Obstetrics and Gynecology, Fudan University, No.1326, Pingliang Road, Shanghai 2000 More

Citation:
Zheng ZM, Wang YY, Chen M, Yang HL, Lai ZZ, Li MQ, Shao J. FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. Int J Med Sci 2022; 19(9):1430-1441. doi:10.7150/ijms.60335. https://www.medsci.org/v19p1430.htm
Other styles

File import instruction

Abstract

Graphic abstract

Uterine corpus endometrial carcinoma (UCEC) is one of the most common types of cancer in women, and the incidence is rapidly increasing. Studies have shown that various signaling pathways serve crucial roles in the tumorigenesis of UCEC, amongst which the Wnt/β-catenin pathway is of great interest due to its crucial role in cell proliferation and the huge potential as a therapeutic target. In the present study, it was shown that FBXO17, which is a member of the F-box family, is abnormally downregulated in UCEC tissues compared with non-tumor endometrial tissues, and this was significantly associated with the clinical histological grade, as well as the abnormal proliferation of the UCEC cell line, Ishikawa, both in vitro and in vivo. Besides, the results suggested that FBXO17 may inhibit the Wnt/β-catenin signaling pathway and influence the expression of adhesion molecules, such as E-cadherin and N-cadherin in Ishikawa cells. In conclusion, these findings indicate that FBXO17 is a novel inhibitor of endometrial tumor development and it likely exerts effects via regulation of the Wnt signaling pathway.

Keywords: FBXO17, endometrial cancer, Wnt/β-catenin pathway, malignant progression, Ishikawa

Citation styles

APA
Zheng, Z.M., Wang, Y.Y., Chen, M., Yang, H.L., Lai, Z.Z., Li, M.Q., Shao, J. (2022). FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. International Journal of Medical Sciences, 19(9), 1430-1441. https://doi.org/10.7150/ijms.60335.

ACS
Zheng, Z.M.; Wang, Y.Y.; Chen, M.; Yang, H.L.; Lai, Z.Z.; Li, M.Q.; Shao, J. FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. Int. J. Med. Sci. 2022, 19 (9), 1430-1441. DOI: 10.7150/ijms.60335.

NLM
Zheng ZM, Wang YY, Chen M, Yang HL, Lai ZZ, Li MQ, Shao J. FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. Int J Med Sci 2022; 19(9):1430-1441. doi:10.7150/ijms.60335. https://www.medsci.org/v19p1430.htm

CSE
Zheng ZM, Wang YY, Chen M, Yang HL, Lai ZZ, Li MQ, Shao J. 2022. FBXO17 Inhibits the Wnt/β-Catenin Pathway and Proliferation of Ishikawa Cells. Int J Med Sci. 19(9):1430-1441.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use